Hyperglycemia in patients with schizophrenia who are treated with olanzapine

被引：13
|
作者：
Lindenmayer, JP
Smith, RC
Singh, A
Parker, B
Chou, E
Kotsaftis, A
机构：
[1] NYU, Sch Med, Dept Psychiat, Hewlett, NY 11557 USA
[2] Manhattan Psychiat Ctr, New York, NY USA
[3] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2001年 / 21卷 / 03期
关键词：
D O I：
10.1097/00004714-200106000-00022
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：351 / 353
页数：3
相关论文
共 50 条
  • [31] Hyperglycemia and olanzapine
    Ober, SK
    Hudak, R
    Rusterholtz, A
    AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (06): : 970 - 970
  • [32] Comparison of discharge rates and drug costs for patients with schizophrenia treated with risperidone or olanzapine
    Kelly, DL
    Nelson, MW
    Love, RC
    Yu, Y
    Conley, RR
    PSYCHIATRIC SERVICES, 2001, 52 (05) : 676 - 678
  • [33] Reduced activity and connectivity of left amygdala in patients with schizophrenia treated with clozapine or olanzapine
    Daniela Mier
    Frederike Schirmbeck
    Gabriela Stoessel
    Christine Esslinger
    Franziska Rausch
    Susanne Englisch
    Sarah Eisenacher
    Lieuwe de Haan
    Andreas Meyer-Lindenberg
    Peter Kirsch
    Mathias Zink
    European Archives of Psychiatry and Clinical Neuroscience, 2019, 269 : 931 - 940
  • [34] Reduced activity and connectivity of left amygdala in patients with schizophrenia treated with clozapine or olanzapine
    Mier, Daniela
    Schirmbeck, Frederike
    Stoessel, Gabriela
    Esslinger, Christine
    Rausch, Franziska
    Englisch, Susanne
    Eisenacher, Sarah
    de Haan, Lieuwe
    Meyer-Lindenberg, Andreas
    Kirsch, Peter
    Zink, Mathias
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2019, 269 (08) : 931 - 940
  • [35] Manic-like symptoms in patients with schizophrenia treated with olanzapine, haloperidol, and placebo
    Baker, RW
    McElroy, SL
    Juliar, BE
    Schuh, LM
    Shao, L
    Stauffer, VL
    SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 195 - 196
  • [36] Analysis of resolution criteria in patients with schizophrenia treated with olanzapine for an acute psychotic episode
    Peuskens, Joseph
    Kaufman, Leonard
    Van Vleymen, Betty
    SCHIZOPHRENIA RESEARCH, 2007, 95 (1-3) : 169 - 173
  • [37] Nocturnal hormone secretion in patients with schizophrenia with predominantly negative symptoms treated with olanzapine
    Mann, K
    Rossbach, W
    Müller, MJ
    Müller-Siecheneder, F
    Pott, T
    Russ, H
    Dittmann, RW
    Hiemke, C
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S235 - S235
  • [38] Olanzapine in adolescents with schizophrenia who manifest suicidal behaviour
    De Giacomo, Andrea
    Lozito, Vito
    Portoghese, Claudia
    EARLY INTERVENTION IN PSYCHIATRY, 2008, 2 (02) : 114 - 115
  • [39] Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol, olanzapine or risperidone
    Larmo, I
    de Nayer, A
    Windhager, E
    Irmansyah
    Lindenbauer, B
    Rittmannsberger, H
    Platz, T
    Jones, AM
    Altman, C
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2005, 20 (08) : 573 - 581
  • [40] Improvement in influences on medication adherence in noncompliant patients with schizophrenia treated with orally disintegrating olanzapine
    Liu-Seifert, H
    Houston, J
    Hill, A
    Kinon, B
    Edwards, S
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S166 - S166
12345